Table 5. Clinicopathological characteristics of MUM1-positive and -negative subgroups of the CD10+GCB patients.
| Variable | MUM1+ (n=66) | MUM1- (n=32) | P-value | ||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | ||||
| Age >60 | 45 | 68.2 | 20 | 62.5 | 0.65 | ||
| Male | 42 | 63.6 | 19 | 59.4 | 0.82 | ||
| B symptoms | 16 | 24.2 | 6 | 19.4 | 0.8 | ||
| Extranodal | 35 | 53 | 18 (n=31) | 58.1 | 0.67 | ||
| BM invasion | 5 (n=64) | 7.8 | 5 (n=29) | 17.2 | 0.28 | ||
| High LDH | 36 | 54.5 | 20 (n=31) | 64.5 | 0.39 | ||
| Stage III-IV | 33 | 50 | 17 (n=31) | 54.8 | 0.67 | ||
| IPI H-I/H | 25 (n=65) | 38.5 | 14 (n=31) | 45.2 | 0.66 | ||
| CD5 | 7 (n=65) | 10.8 | 1 | 3.1 | 0.44 | ||
| EBV-ISH | 1 | 1.5 | 2 | 6.2 | 0.25 | ||